Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04692714
Other study ID # 69HCL20_0872
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 16, 2022
Est. completion date April 16, 2028

Study information

Verified date May 2022
Source Hospices Civils de Lyon
Contact Sébastien LUSTIG, Professor
Phone 33 (0) 4 26 10 92 98
Email sebastien.lustig@chu-lyon.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Total knee replacement surgery (TKA) is a treatment for advanced tibial-femoral osteoarthritis. This intervention is justified in case of significant discomfort and failure of medical treatment. It aims to replace the native internal and external femoro-tibial joints with a joint between a femoral implant and a tibial implant. Implants can be cemented or cementless. The longevity of these implants depends among other things on the quality of the bone fixation of the implants. It is therefore essential that this fixation be evaluated. The advantages of an uncemented TKA are the preservation of bone stock, the absence of wear by cement debris and prolonged fixation thanks to osseointegration. These characteristics are all the more interesting in a young population. Numerous studies have been carried out on the survival of TKA with and without cement. The results found are not unanimous and mainly concern the survival of the implants and the presence of radiological signs of loosening. In addition, no study has evaluated the results of TKA with or without cement implanted using robotic assistance. The precision provided by the robotic system could improve the results of these uncemented implants. Very few studies are interested in the functional results according to the cementation or not of TKA. And most of these studies do not have a high level of methodological evidence. We would like to prospectively evaluate the functional results, survival, as well as the rate of radiological border after TKA with or without cement posed with robotic assistance, in the short and medium term.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date April 16, 2028
Est. primary completion date November 16, 2024
Accepts healthy volunteers No
Gender All
Age group 50 Years to 80 Years
Eligibility Inclusion Criteria: - Diagnosis of internal, external or global femorotibial knee osteoarthritis - Indication for first-line total knee arthroplasty - having given informed consent - Affiliated with a social security scheme - Patient being able to understand the objectives of the study and willing to comply with postoperative instructions. Exclusion Criteria: - Patient with rheumatoid arthritis - Preoperative flexion less than 90 ° - Prosthesis associated with an osteotomy - History of surgery on the operated knee, except arthroscopy - Poor bone quality assessed by the surgeon - Knee deformation greater than 10 ° preoperatively (HKA) - Pregnant or breastfeeding Women - Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care, persons admitted to a health or social institution for purposes other than research - Adults subject to a legal protection measure - Patient already participating to another clinical trial that might jeopardize the current trial

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Knee prosthesis implementation with additional cement
During surgery, a TRIATHLON prosthesis will be implemented with the MAKO robot with additional cement.
Knee prosthesis implementation without additional cement
During surgery, a TRIATHLON prosthesis will be implemented with the MAKO robot without additional cement.

Locations

Country Name City State
France Chirurgie Orthopédique et Traumatologique Centre Hospitalier Lyon Sud, Hospices Civils de Lyon Lyon
France Department of orthopedic surgery, Hopital Nord Croix-Rousse- Hospices Civils de Lyon Lyon

Sponsors (2)

Lead Sponsor Collaborator
Hospices Civils de Lyon Stryker Nordic

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in International Knee Society (IKS) function score at 12 Months The knee function will be evaluated using the delta of the IKS function score between baseline (before surgery) and 1 year after total knee arthroplasty, and compared between the 2 arms. Baseline and 12 months
Secondary Change from baseline in IKS objective score at 12 Months The knee function will be evaluated using the delta of the IKS objective score between baseline (before surgery) and 1 year after total knee arthroplasty, and compared between the 2 arms. Baseline and 12 months
Secondary Change from baseline in IKS function score at 60 Months The knee function will be evaluated using the delta of the IKS function score between baseline (before surgery) and 5 years after total knee arthroplasty. Baseline and 60 months
Secondary Change from baseline in IKS objective score at 60 Months The knee function will be evaluated using the delta of the IKS objective score between baseline (before surgery) and 5 years after total knee arthroplasty. Baseline and 60 months
Secondary Forgotten joint score at 12 Months Patient prosthesis acceptability will be evaluated thanks to the forgotten joint score 12 months after total knee arthroplasty 12 months
Secondary Forgotten joint score at 60 Months Patient prosthesis acceptability will be evaluated thanks to the forgotten joint score 60 months after total knee arthroplasty 60 months
Secondary Presence of progressive radiological border at 12 Months Progressive radiological border will be judged significant if it is at least 2 mm long at the interface between the implant (or cement) and the bone, or if it progresses in comparison to immediate post-surgical time. 12 months
Secondary Unsealing free survival at 60 months Unsealing free survival of knee prosthesis 60 months after total knee arthroplasty 60 months
See also
  Status Clinical Trial Phase
Completed NCT03542981 - Interferential Current Therapy After Total Knee Arthroplasty N/A
Recruiting NCT04458480 - Effect of Fast Inpatient Rehabilitation After TKA
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Recruiting NCT06061367 - Muscles Strength and Gait Parameteres After TKA
Recruiting NCT05391828 - Persona MC vs PS RCT With ROSA N/A
Active, not recruiting NCT04850300 - Efficiency Assessment of the Methodology for the Follow-up of Patients With Knee Prostheses Phase 3
Completed NCT05635916 - Trial of Liposomal Bupivacaine for TKA Phase 4
Enrolling by invitation NCT05130216 - Genicular Nerve Radiofrequency Ablation for Chronic Knee Pain After Total Knee Arthroplasty
Withdrawn NCT02495805 - Ultrasound-guided Continuous Proximal Adductor Canal vs Continuous Femoral Nerve Block for Postoperative Pain Control and Rehabilitation Following Total Knee Arthroplasty N/A
Completed NCT03206554 - Local Infiltration Analgesia in Total Knee Arthroplasty Phase 2
Completed NCT01616836 - Optimizing Pain and Rehabilitation After Knee Arthroplasty Phase 3
Withdrawn NCT01511211 - Duration of Leg Nerve Blocks With Dexamethasone Added to Local Anesthetic Phase 4
Not yet recruiting NCT00958945 - Retrospective Chart Analysis in the Effective Use of FloSeal in Post-Operative Joint Replacements N/A
Completed NCT00985920 - Topical Tranexamic Acid for Total Knee Arthroplasty Phase 4
Completed NCT00761956 - A Study to Compare the NexGen CR and CR-Flex Knee Implants N/A
Completed NCT03289247 - Tissue Adhaesive in Wound Closure Following Primary Total Knee Arthroplasty N/A
Terminated NCT03316118 - US Guided GNB vs Saline Injection for TKA Phase 4
Recruiting NCT05962970 - Continuous Adductor Canal Block in Fast Track Total Knee Arthroplasty N/A
Completed NCT03317834 - Navio With Total Knee Arthroplasty
Enrolling by invitation NCT06188091 - Joint Movement to Increase Range of Motion in Knee Joint After Primary Total Knee Arthroplasty N/A

External Links